CY1112045T1 - Ενδοαρθρικες φαρμακοτεχνικες μορφες στανοζολολης - Google Patents

Ενδοαρθρικες φαρμακοτεχνικες μορφες στανοζολολης

Info

Publication number
CY1112045T1
CY1112045T1 CY20111101086T CY111101086T CY1112045T1 CY 1112045 T1 CY1112045 T1 CY 1112045T1 CY 20111101086 T CY20111101086 T CY 20111101086T CY 111101086 T CY111101086 T CY 111101086T CY 1112045 T1 CY1112045 T1 CY 1112045T1
Authority
CY
Cyprus
Prior art keywords
stanozolol
introduction
pharmaceutical forms
pharmaceutical
forms
Prior art date
Application number
CY20111101086T
Other languages
English (en)
Inventor
Paolo Predieri
Original Assignee
Acme Drugs S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acme Drugs S.R.L. filed Critical Acme Drugs S.R.L.
Publication of CY1112045T1 publication Critical patent/CY1112045T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Αποκαλύπτονται ενδοαρθρικές φαρμακοτεχνικές μορφές που περιλαμβάνουν στανοζολόλη και έναν κατάλληλο φορέα.
CY20111101086T 2006-08-10 2011-11-11 Ενδοαρθρικες φαρμακοτεχνικες μορφες στανοζολολης CY1112045T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001609A ITMI20061609A1 (it) 2006-08-10 2006-08-10 Formulazioni intrasinoviali di stanozololo
EP07014741A EP1891940B1 (en) 2006-08-10 2007-07-26 Intrasynovial formulations of stanozolol

Publications (1)

Publication Number Publication Date
CY1112045T1 true CY1112045T1 (el) 2015-11-04

Family

ID=38780812

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101086T CY1112045T1 (el) 2006-08-10 2011-11-11 Ενδοαρθρικες φαρμακοτεχνικες μορφες στανοζολολης

Country Status (9)

Country Link
EP (1) EP1891940B1 (el)
AT (1) ATE524162T1 (el)
CY (1) CY1112045T1 (el)
DK (1) DK1891940T3 (el)
ES (1) ES2370803T3 (el)
IT (1) ITMI20061609A1 (el)
PL (1) PL1891940T3 (el)
PT (1) PT1891940E (el)
SI (1) SI1891940T1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800003841A1 (it) * 2018-03-21 2019-09-21 Acme Drugs S R L Coniugati di stanozololo e acido ialuronico

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1502593B1 (en) * 2003-07-29 2007-02-14 Acme S.R.L. The use of Stanozolol for the preparation of anti-inflammatory and anti-degenerative drugs

Also Published As

Publication number Publication date
PT1891940E (pt) 2011-11-10
ITMI20061609A1 (it) 2008-02-11
SI1891940T1 (sl) 2011-12-30
ATE524162T1 (de) 2011-09-15
ES2370803T3 (es) 2011-12-22
EP1891940A1 (en) 2008-02-27
PL1891940T3 (pl) 2012-02-29
EP1891940B1 (en) 2011-09-14
DK1891940T3 (da) 2011-11-28

Similar Documents

Publication Publication Date Title
NL300936I2 (nl) Semaglutide
LTC2548560I2 (lt) Kompozicijos ir būdai, skirti SMN2 splaisingo moduliavimui
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no) Farmasøytiske formuleringer
DE112006001565A5 (de) Nanopartikel-Wirkstoff-Konjugate
DK1812895T3 (da) Stofkilde
DK1812025T3 (da) Stabiliserede bakteriofagformuleringer
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
ATE447991T1 (de) Arzneimittelabgabevorrichtung
DK1957073T3 (da) Lægemiddel
DK1750683T3 (da) Formuleringer med langvarig frigivelse
NL1031218A1 (nl) Oxyindoolderivaten.
DK1871181T3 (da) Kosttilskud til HIV-patienter
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
DK2918286T3 (da) En farmaceutisk formulering
DK1954288T3 (da) Amidin-derivater og anvendelse deraf som lægemiddel
CY1112045T1 (el) Ενδοαρθρικες φαρμακοτεχνικες μορφες στανοζολολης
ITMI20051313A1 (it) Tutore per ginocchio
FR2868047B1 (fr) Capsule de distribution
IS8612A (is) Stöðugar statínlyfjasamsetningar
FR2892698B1 (fr) Quille active
SE0400990D0 (sv) Läkemedel
UA10262S (uk) Упаковка для біологічно-активної добавки
FI20040146A (fi) Farmaseuttiset valmisteet